European Low Dose Initiative
MELODI is a European Platform dedicated to low dose radiation risk research. In 2010 MELODI was founded as a registered association with 15 members.
The purpose of MELODI is:
EUROPE 2020 Strategy
Comunication with stakeholders
Cooperation with WHO and IAEA
News and Updates
2022 MELODI Statement
Alongside the updated SRA, a new MELODI Statement for 2022 is now available for comment here. The Statements are issued to inform on relevant topics for inclusion in EC, national and EC funded project calls for research proposals. Comments are invited on this...
MELODI Strategic Research Agenda 2022
The SRA working group has recently completed a revision of the MELODI SRA, available here. As usual, we are inviting comments on this consultation draft. Please use the comment box in the full news story to post any comments you may have. The original consultation...
7th International Workshop on the Causes of Childhood Leukemia
28-30 November 2022 at Kolpinghaus in Munich, Germany. On a nearly bi-annual basis, the BfS (Federal Office for Radiation Protection) - and varying partners - jointly organized six scientific meetings to discuss the knowns and unknowns and to define a long-term...
More about MELODI
Based on the outcomes of the yearly MELODI workshops a Strategic Research Agenda (SRA) is being progressively developed. To assure an open and vivid discussion and development of the SRA the contribution from a large number of scientists and stakeholders is needed. More information about the SRA and the ongoing discussion can be found under SRA. Comments are welcome.
In parallel to the SRA a statement on a short- to medium-term research agenda for R&T projects is developed to improve the scientific basis for radiation protection in Europe giving guidance for pending EURATOM R&T project calls. These recommendations can be found under MELODI documents.